Concepedia

Su Jingwen

SJ

Statistics

Publications

6

Citations

552

H-Index

6

Active since

2019

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Shanghai Cancer Institute

Renji Hospital

Shanghai Jiao Tong University

Su Jingwen is an author at State Key Laboratory of Oncogene and Related Genes specializing in cancer immunotherapy, oncology, and immunotherapy.

Publications per year

2019–2023

6

Publications

6

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

Hong Luo, Su Jingwen, Ruixin Sun et al. · Clinical Cancer Research · 2020 · 179 citations · Full text

, , +17

Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma

Xiuqi Wu, Hong Luo, Bizhi Shi et al. · Molecular Therapy · 2019 · 157 citations · Full text

, , +17

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

Ruixin Sun, Hong Luo, Su Jingwen et al. · Molecular Therapy · 2020 · 120 citations · Full text

, , +17

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells

Hong Luo, Xiuqi Wu, Ruixin Sun et al. · Frontiers in Oncology · 2019 · 48 citations · Full text

, , +17

Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death

Yi Wang, Honghong Zhang, Guoxiu Du et al. · Molecular Therapy · 2022 · 25 citations · Full text

, , +16

1–5 of 6